| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 01/20/2005 | US20050014741 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/19/2005 | EP1498416A1 A process for the optical purification of benzimidazole derivatives |
| 01/18/2005 | US6844443 Hypotensive agents; cardiovascular disorders |
| 01/18/2005 | US6844366 Such as N-hydroxy-2(R)-((3,4-methylenedioxybenzyl)-(4-methoxy-2,3,6-trimethylbenzene-sulfonyl) amino)-3-methylbutyramide for treatment of diseases treatable with pro-collagen C-proteinase inhibitors |
| 01/18/2005 | US6844342 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
| 01/13/2005 | WO2005003098A1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents |
| 01/13/2005 | WO2005003081A2 Sulfonimide containing compounds and their use in polymer electrolyte membranes for electrochemical cells |
| 01/13/2005 | WO2005002520A2 Ophthalmic compositions for treating ocular hypertension |
| 01/13/2005 | WO2005002503A2 Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| 01/13/2005 | WO2004072047A8 Indoles, benzimidazoles or naphhimidazoles as histone deacetylase (hdac) inhibitors |
| 01/13/2005 | WO2004050035A3 Benzimidazoles and analogs thereof as antivirals |
| 01/13/2005 | US20050010060 Novel quinones as disease therapies |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/13/2005 | US20050009829 1-Substituted 2-carboxamide derivatives of fused ring imidazoles, e.g., -[5-(5-Chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-1H-benzoimidazole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide |
| 01/13/2005 | US20050009054 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsDNA |
| 01/13/2005 | US20050008968 Basic compound, resist composition and patterning process |
| 01/13/2005 | US20050008895 Emission of blue, green light |
| 01/13/2005 | CA2531060A1 Heterocyclically-substitued pentanol derivatives, process for their production and their use as anti-inflammatory agents |
| 01/13/2005 | CA2530081A1 Ophthalmic compositions for treating ocular hypertension |
| 01/13/2005 | CA2525580A1 Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1494668A2 Use of benzimidazole analogs in the treatment of cell proliferation |
| 01/12/2005 | EP1494667A1 Imidazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP0944604B1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/12/2005 | CN1562984A Compound of hydrosulfuryl-substitution azacycle |
| 01/12/2005 | CN1184208C Substituted benzimidazoles and their prepn. and use |
| 01/11/2005 | US6841566 Viral polymerase inhibitors |
| 01/06/2005 | WO2005001979A2 Fluorinated sulfonamide compounds and polymer electrolyte membranes pepared therefrom for use in electrochemical cells |
| 01/06/2005 | WO2005000973A1 Benzimidazolone compound |
| 01/06/2005 | WO2005000800A1 Cathepsin cysteine protease inhibitors |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004198 Central nervous system, lipid metabolism and gall function disorders; ectoparasite infections; suppressing snoring |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004188 cytotoxic secondary metabolites; selective towards cancer cells magnesium ion binders |
| 01/06/2005 | US20050004153 inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); use treating transplant rejection, rheumatoid arthritis, diabetes, inflammatory bowel disease, and chronic obstructive pulmonary disease; 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 01/06/2005 | US20050004133 Inhibiting ligand gated ion channel vanilloid receptor (VR1); pain relievers; such as 6-(3,4-dichloro-phenyl)-N-(2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-nicotinamide |
| 01/06/2005 | CA2530068A1 Cyanoalklamino derivatives useful as cathepsin cysteine protease inhibitors |
| 01/06/2005 | CA2526487A1 Heterocyclic methyl sulfone derivative |
| 01/05/2005 | EP1493742A1 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 01/05/2005 | CN1561212A Benzimidazolidinone derivatives as muscarinic agents |
| 01/05/2005 | CN1561211A Nociceptin analogs |
| 01/05/2005 | CN1560038A Compound of substituted benzo heterocyclic by electrophosphorescence and luminous ligand thereof |
| 01/05/2005 | CN1183127C Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 01/05/2005 | CN1183118C 4-alkoxy-cyclohexane-1-amino carboxylic acid esters and method for production thereof |
| 01/05/2005 | CN1183092C Intermediates and process for producing fluorine-contg. amino acid compound by using same |
| 01/04/2005 | US6838483 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 12/30/2004 | US20040266844 Antimicrobial and radioprotective compounds |
| 12/30/2004 | US20040266769 Antiinflammatory agents; inflammatory bowel disorders; capable of complexing with a deacetylase catalytic site and/or a metal ion |
| 12/29/2004 | WO2004078119A3 Substituted thiophenes with antibacterial activity |
| 12/29/2004 | EP1491212A1 Remedy for sleep disturbance |
| 12/29/2004 | EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators |
| 12/29/2004 | EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/29/2004 | EP1490058A1 Peroxisome proliferator activated receptor modulators |
| 12/29/2004 | EP1177178B1 Heterocyclically substituted benzimidazoles, the production and application thereof |
| 12/29/2004 | EP0874626B1 Use of inhibitors of retinoic acid activity for wound healing |
| 12/29/2004 | CN1558761A Substituted benzimidazole compounds and their use for the treatment of cancer |
| 12/29/2004 | CN1182122C Synthesis path of Timisatem |
| 12/23/2004 | WO2004110986A1 Benzamide derivative or salt thereof |
| 12/23/2004 | US20040260095 human immunodeficiency virus (HIV) protease inhibitors; AIDS; prophylaxis |
| 12/23/2004 | US20040259927 Compounds for treatment of sleep apnea, respiratory system disorders or kidney failure |
| 12/23/2004 | US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence |
| 12/23/2004 | US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 12/23/2004 | US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents |
| 12/23/2004 | US20040259804 (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 12/23/2004 | US20040259164 Capture and release based isotope tagged peptides and methods for using the same |
| 12/23/2004 | DE10323701A1 Verfahren zur Synthese heterocyclischer Verbindungen Process for the synthesis of heterocyclic compounds |
| 12/23/2004 | CA2529729A1 New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 12/23/2004 | CA2528993A1 Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
| 12/23/2004 | CA2526387A1 Benzamide derivative or salt thereof |
| 12/23/2004 | CA2526285A1 Inhibitors of p38 and methods of using the same |
| 12/22/2004 | EP1487843A2 Substituted phenylacetic acids |
| 12/22/2004 | EP1487796A1 Substituted biaryl amides as c5a receptor modulators |
| 12/22/2004 | EP1086076B1 Sulfonamide inhibitors of aspartyl protease |
| 12/22/2004 | EP1080066A4 Bioreductive cytotoxic agents |
| 12/22/2004 | EP0987254B1 Novel cyclic diamine compounds and medicine containing the same |
| 12/22/2004 | EP0872477B1 Naphthol derivative and process for preparing the same |
| 12/22/2004 | CN1181055C Alanine class compound, its preparing method and use |
| 12/21/2004 | CA2241904C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 12/16/2004 | WO2004108712A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 12/16/2004 | WO2004108689A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 12/16/2004 | WO2004108688A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 12/16/2004 | WO2004108687A2 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection |
| 12/16/2004 | WO2004108686A2 Benzimidazole compounds having hypoglycemic activity |
| 12/16/2004 | WO2004108684A1 Novel azole derivative having antifungal activity |
| 12/16/2004 | WO2004108133A2 Modulators of vr1 receptor |
| 12/16/2004 | WO2004065383A3 Novel synthesis of irbesartan |
| 12/16/2004 | WO2003063797A8 Cycloalkyl inhibitors of potassium channel function |
| 12/16/2004 | US20040254382 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 12/16/2004 | US20040254376 Cyclic amidine derivative |
| 12/16/2004 | US20040254220 Histone deacetylase inhibitors |
| 12/16/2004 | CA2528925A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 12/16/2004 | CA2528924A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 12/16/2004 | CA2528044A1 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection |
| 12/16/2004 | CA2527313A1 N-alkynyl-2-(substituted aryloxy) alkylthioamide derivatives as fungicides |
| 12/15/2004 | EP1486552A1 Organic electroluminescent material, organic electroluminescent device, and heterocycle-containing iridium complex compound |
| 12/15/2004 | EP1486486A2 Substituted B-thiocarboxylic acids |
| 12/15/2004 | EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 12/15/2004 | EP1485358A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
| 12/15/2004 | EP1485057A2 Derivatives of azaspiro compounds for the treatment of pain |